表紙
市場調査レポート

いびき防止デバイス・いびき治療手術の世界市場の動向・予測 〜2020年:デバイスタイプ・外科手術

Anti-snoring Devices and Snoring Surgery Market by Device Type (MADs, TRD, Nasal Dilator, Chin Strap, Position Control, Pillows, TSD, EPAP), Surgical Procedure (UP3, LAUP, RFA, Sclerotherapy, Pillar, Others) - Global Trends & Forecast to 2020

発行 MarketsandMarkets 商品コード 339917
出版日 ページ情報 英文 133 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
いびき防止デバイス・いびき治療手術の世界市場の動向・予測 〜2020年:デバイスタイプ・外科手術 Anti-snoring Devices and Snoring Surgery Market by Device Type (MADs, TRD, Nasal Dilator, Chin Strap, Position Control, Pillows, TSD, EPAP), Surgical Procedure (UP3, LAUP, RFA, Sclerotherapy, Pillar, Others) - Global Trends & Forecast to 2020
出版日: 2015年09月15日 ページ情報: 英文 133 Pages
概要

いびき治療の市場は2015年から2020年にかけて10.6%のCAGRで推移し、2015年の7億4470万米ドルから、2020年には12億3260万米ドルの規模に成長すると予測されています。いびきの有害作用に関する認知度が高まったことが世界のいびき治療市場の成長の大きな要因となっています。

当レポートでは、世界のいびき防止デバイスおよび治療手術の市場について調査し、デバイスおよび手術の種類と概要、市場成長への各種影響因子の分析、デバイスおよび手術区分別の主要動向と市場規模の推移と予測、地域および主要国の動向、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 重要考察

  • いびき防止デバイス市場:タイプ別
  • いびき防止外科手術市場:タイプ別

第5章 市場概要

  • イントロダクション
  • 市場区分
    • デバイスタイプ別
    • 手術タイプ別
    • 地域別
  • 市場力学
    • 成長推進因子
    • 成長阻害因子
    • 市場機会

第6章 いびき防止デバイス市場:タイプ別

  • イントロダクション
    • 口腔アプライアンス/マウスピース
      • 下顎前方移動装置 (MAD)
        • 非カスタムMAD
        • カスタムMAD
      • 舌前方維持装置 (TRD)
    • 鼻用デバイス
      • 鼻拡張器 (鼻ストリップ)
      • その他の鼻用デバイス (ステント・クリップ・鼻中隔刺激器)
    • 位置調整デバイス
    • あごストラップ
    • 舌安定化器具 (TSD)
    • EPAP (呼気陽圧) 治療デバイス

第7章 いびき防止外科手術市場:タイプ別

  • イントロダクション
  • 口蓋垂軟口蓋咽頭形成術 (UPPP)
  • レーザー口蓋垂軟口蓋形成術 (LAUP)
  • 高周波アブレーション (ソムノプラスティ)
  • ピラープロシージャー
  • 注入式スノアプラスティ/硬化療法
  • 口蓋硬化手術
  • その他のいびき手術

第8章 地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他
  • アジア
  • その他

第9章 競合環境

  • 概要
    • 新製品の投入
    • 買収
    • その他の成長戦略

第10章 企業プロファイル

  • イントロダクション
  • SLEEPING WELL, LLC
  • APNEA SCIENCES CORPORATION
  • THE PURE SLEEP COMPANY
  • SOMNOMED LIMITED
  • AIRWAY MANAGEMENT INC.
  • THERAVENT, INC.
  • TOMED DR. TOUSSAINT GMBH
  • GLAXOSMITHKLINE, PLC
  • MEDITAS LTD.
  • INNOVATIVE HEALTH TECHNOLOGIES (NZ) LIMITED
    • 財務動向
    • 製品・サービス
    • 主要戦略
    • 近年の発展動向、など

第11章 付録

図表

目次
Product Code: MD 3739

The anti-snoring treatments market is poised to reach USD 1,232.6 million by 2020 from USD 744.7 million in 2015, growing at a CAGR of 10.6% from 2015 to 2020. This market is categorized on the basis of device type, surgical procedure, and region. The anti-snoring devices market is expected to grow at the highest CAGR in the coming five years.

Major factors contributing to the growth of the global anti-snoring treatments market include the growing awareness on the ill effects of snoring. Key players and other stakeholders in this market are taking initiatives to create awareness on the problems of snoring. For instance, the British Snoring and Sleep Apnoea Association (BSSAA) organize the National Stop Snoring Week every year. In 2015, the BSSAA organized this activity from 20th April to 25th April. The aim of this event is to create awareness among people about the consequences of snoring and sleep apnea, and the available treatments for these disorders. In 2014, SleepPath (U.S.), a company providing anti-snoring t-shirts for people suffering from positional snoring, released a video named Snoring Your Best Pick Up Lines. This is a humorous video created to spread public awareness regarding snoring. Other factors responsible for the growth of this market include the growing geriatric and obese population, presence of a large number of cigarette smokers and alcoholics, and a large pool of untapped snoring population.

North America and Europe are the fastest-growing markets. High growth in these markets is attributed to the growing awareness on the ill effects of snoring, presence of a large number of market players, and presence of a large pool of untreated snoring population..

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the anti-snoring treatments market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Information on the product portfolios of the key players in the anti-snoring treatments market. The report analyzes this market by device type, surgical procedure, and region
  • Product Development/Innovation: Insights on R&D activities, and new product launches in the anti-snoring treatments market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of some of the key players in the anti-snoring treatments market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various anti-snoring products across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the anti-snoring treatments market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKET SEGMENTATION
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.3. KEY DATA FROM SECONDARY SOURCES
  • 2.4. KEY DATA FROM PRIMARY SOURCES
  • 2.5. KEY INDUSTRY INSIGHTS
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ANTI-SNORING DEVICES MARKET, BY TYPE
  • 4.2. ANTI-SNORING SURGICAL PROCEDURES MARKET, BY TYPE

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY DEVICE TYPE
    • 5.2.2. BY SURGICAL PROCEDURE TYPE
    • 5.2.3. BY REGION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Rising awareness in developed countries about the ill effects of snoring and benefits of associated treatments
      • 5.3.1.2. Rising geriatric and obese population
      • 5.3.1.3. Growing cigarette and alcohol consumption
      • 5.3.1.4. Technological advancements in anti-snoring devices
    • 5.3.2. RESTRAINTS/LIMITATIONS
      • 5.3.2.1. Poor efficacy and lack of scientific validation of the anti-snoring devices currently available in the market
      • 5.3.2.2. High cost of custom-made oral appliances
      • 5.3.2.3. Social stigma associated with snoring
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Presence of a large untreated population
      • 5.3.3.2. Developing countries to offer high growth opportunities

6. ANTI-SNORING DEVICES MARKET, BY TYPE

  • 6.1. INTRODUCTION
    • 6.1.1. ORAL APPLIANCES/MOUTHPIECES
      • 6.1.1.1. Mandibular advancement devices (MADs)
        • 6.1.1.1.1. Non-custom MADs
        • 6.1.1.1.2. Custom-made MADs
      • 6.1.1.2. Tongue-retaining devices (TRDs)
    • 6.1.2. NASAL DEVICES
      • 6.1.2.1. External nasal dilators (nasal strips)
      • 6.1.2.2. Other nasal devices (nasal stents, nasal clips, and septal stimulators)
    • 6.1.3. POSITION CONTROL DEVICES
    • 6.1.4. CHIN STRAPS
    • 6.1.5. TONGUE-STABILIZING DEVICES (TSDS)
    • 6.1.6. EPAP THERAPY DEVICES

7. ANTI-SNORING SURGICAL PROCEDURES MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. UVULOPALATOPHARYNGOPLASTY (UPPP)
  • 7.3. LASER-ASSISTED UVULOPALATOPLASTY (LAUP)
  • 7.4. RADIOFREQUENCY ABLATION (SOMNOPLASTY)
  • 7.5. PILLAR PROCEDURE
  • 7.6. INJECTION SNOREPLASTY/SCLEROTHERAPY
  • 7.7. PALATAL STIFFENING PROCEDURES
  • 7.8. OTHER ANTI-SNORING SURGICAL PROCEDURES

8. REGIONAL ANALYSIS

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
    • 8.2.2. CANADA
  • 8.3. EUROPE
    • 8.3.1. GERMANY
    • 8.3.2. U.K.
    • 8.3.3. FRANCE
    • 8.3.4. REST OF EUROPE (ROE)
  • 8.4. ASIA
  • 8.5. ROW

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
    • 9.1.1. NEW PRODUCT LAUNCHES
    • 9.1.2. ACQUISITIONS
    • 9.1.3. OTHER GROWTH STRATEGIES

10. COMPANY PROFILES

  • 10.1. INTRODUCTION
  • 10.2. SLEEPING WELL, LLC
  • 10.3. APNEA SCIENCES CORPORATION
  • 10.4. THE PURE SLEEP COMPANY
  • 10.5. SOMNOMED LIMITED
  • 10.6. AIRWAY MANAGEMENT INC.
  • 10.7. THERAVENT, INC.
  • 10.8. TOMED DR. TOUSSAINT GMBH
  • 10.9. GLAXOSMITHKLINE, PLC
  • 10.10. MEDITAS LTD.
  • 10.11. INNOVATIVE HEALTH TECHNOLOGIES (NZ) LIMITED

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

11. APPENDIX

  • 11.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 11.2. DISCUSSION GUIDE
  • 11.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.4. AVAILABLE CUSTOMIZATIONS
  • 11.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GROWING AWARENESS ABOUT SNORING AND RELATED CONDITIONS TO DRIVE THE MARKET GROWTH
  • TABLE 2: POOR EFFICACY AND LACK OF SCIENTIFIC VALIDATION OF ANTI-SNORING DEVICES IS A MAJOR MARKET RESTRAINT
  • TABLE 3: PRESENCE OF LARGE UNTREATED POPULATION OFFERS HIGH GROWTH OPPORTUNITIES FOR THE ANTI-SNORING TREATMENTS MARKET
  • TABLE 4: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 5: ANTI-SNORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 6: NORTH AMERICA: ANTI-SNORING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 7: EUROPE: ANTI-SNORING DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 8: COMPARISON OF KEY ANTI-SNORING ORAL APPLIANCES AVAILABLE IN THE MARKET
  • TABLE 9: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 10: ORAL APPLIANCES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: NORTH AMERICA: ORAL APPLIANCES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 12: EUROPE: ORAL APPLIANCES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 13: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 14: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 16: EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: NON-CUSTOM MADS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: NORTH AMERICA: NON-CUSTOM MADS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 19: EUROPE: NON-CUSTOM MADS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 20: CUSTOM-MADE MADS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: NORTH AMERICA: CUSTOM-MADE MADS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 22: EUROPE: CUSTOM-MADE MADS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 23: TONGUE-RETAINING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: NORTH AMERICA: TONGUE-RETAINING DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 25: EUROPE: TONGUE-RETAINING DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD THOUSAND)
  • TABLE 26: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 27: NASAL DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: NORTH AMERICA: NASAL DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: EUROPE: NASAL DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 30: EXTERNAL NASAL DILATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: NORTH AMERICA: EXTERNAL NASAL DILATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: EUROPE: EXTERNAL NASAL DILATORS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: OTHER NASAL DEVICES
  • TABLE 34: OTHER NASAL DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: NORTH AMERICA: OTHER NASAL DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 36: EUROPE: OTHER NASAL DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 37: POSITION CONTROL DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: NORTH AMERICA: POSITION CONTROL DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 39: EUROPE: POSITION CONTROL DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 40: CHIN STRAPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 41: NORTH AMERICA: CHIN STRAPS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 42: EUROPE: CHIN STRAPS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 43: TONGUE-STABILIZING DEVICE (TSD): AVEOTSD
  • TABLE 44: TONGUE STABILIZING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 45: NORTH AMERICA: TONGUE STABILIZING DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 46: EUROPE: TONGUE STABILIZING DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 47: EPAP THERAPY DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 48: NORTH AMERICA: EPAP THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 49: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 50: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 51: NORTH AMERICA: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 52: EUROPE: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 53: UVULOPALATOPHARYNGOPLASTY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 54: LASER-ASSISTED UVULOPALATOPLASTY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 55: RADIOFREQUENCY ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 56: PILLAR PROCEDURE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 57: INJECTION SNOREPLASTY MARKET SIZE, BY REGION, 2013-2020 (USD THOUSAND)
  • TABLE 58: PALATAL STIFFENING PROCEDURES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 59: OTHER SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 60: ANTI-SNORING TREATMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 61: ANTI-SNORING TREATMENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 62: NORTH AMERICA: ANTI-SNORING TREATMENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 63: EUROPE: ANTI-SNORING TREATMENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 64: NORTH AMERICA: ANTI-SNORING TREATMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 65: NORTH AMERICA: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 66: NORTH AMERICA: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 67: NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 68: NORTH AMERICA: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 69: NORTH AMERICA: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 70: U.S.: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 71: U.S.: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 72: U.S.: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 73: U.S.: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 74: CANADA: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 75: CANADA: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 76: CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 77: CANADA: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 78: EUROPE: ANTI-SNORING TREATMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 79: EUROPE: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 80: EUROPE: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 81: EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 82: EUROPE: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 83: EUROPE: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 84: GERMANY: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 85: GERMANY: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 86: GERMANY: MANDIBULAR ADVANCEMENT DEVICES (MADS) MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 87: GERMANY: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 88: U.K.: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 89: U.K.: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD THOUSAND)
  • TABLE 90: U.K.: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 91: U.K.: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 92: FRANCE: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 93: FRANCE: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 94: FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 95: FRANCE: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 96: ROE: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 97: ROE: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD THOUSAND)
  • TABLE 98: ROE: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 99: ROE: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 100: ASIA: ANTI-SNORING TREATMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 101: ASIA: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 102: ASIA: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 103: ASIA: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 104: ASIA: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 105: ASIA: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 106: ROW: ANTI-SNORING TREATMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 107: ROW: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 108: ROW: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 109: ROW: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 110: ROW: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 111: ROW: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 112: NEW PRODUCT LAUNCHES, 2012-2015
  • TABLE 113: ACQUISITIONS, 2012-2015
  • TABLE 114: OTHER GROWTH STRATEGIES, 2012-2015
  • TABLE 115: COMPARISON OF KEY ANTI-SNORING ORAL APPLIANCES AVAILABLE IN THE MARKET
  • TABLE 116: EXCHANGE RATES (UTILIZED FOR CONVERSION OF GBP TO USD)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: ANTI-SNORING DEVICES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 3: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 4: COUNTRY-LEVEL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY TYPE OF TREATMENT, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: ANTI-SNORING TREATMENTS MARKET SNAPSHOT, 2015 VS. 2020
  • FIGURE 8: ORAL APPLIANCES IS THE FASTEST-GROWING DEVICE SEGMENT
  • FIGURE 9: NASAL DEVICES IS THE SECOND LARGEST SEGMENT IN THE DEVICES MARKET AND IT IS DOMINATED BY EXTERNAL NASAL DILATORS (NASAL STRIPS)
  • FIGURE 10: IN 2015, UPPP TO COMMAND THE LARGEST SHARE OF THE SURGICAL PROCEDURES MARKET
  • FIGURE 11: NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE IN 2015, AND GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 12: ORAL APPLIANCES SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 13: MADS SEGMENT TO PROVIDE HIGH-GROWTH OPPORTUNITIES IN THE FORECAST PERIOD
  • FIGURE 14: ORAL APPLIANCES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE ANTI-SNORING DEVICES MARKET IN 2015
  • FIGURE 15: THE U.S. TO WITNESS HIGHEST GROWTH BETWEEN 2015 & 2020
  • FIGURE 16: UPPP, LAUP, AND RFA ARE EXPECTED TO BE THE MAJOR SEGMENTS IN THE SURGICAL PROCEDURES MARKET BETWEEN 2015 TO 2020
  • FIGURE 17: ANTI-SNORING TREATMENTS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 18: ANTI-SNORING DEVICES MARKET: ORAL APPLIANCES ARE EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: MADS ARE EXPECTED TO COMMAND THE LARGEST SHARE IN THE ORAL APPLIANCES SEGMENT IN 2015
  • FIGURE 20: NON-CUSTOM MADS ARE SLATED TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 21: RADIOFREQUENCY ABLATION PROCEDURES MARKET IS EXPECTED TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 22: NORTH AMERICAN ANTI-SNORING TREATMENTS MARKET SNAPSHOT
  • FIGURE 23: EUROPEAN ANTI-SNORING TREATMENTS MARKET SNAPSHOT
  • FIGURE 24: ASIA: ANTI-SNORING DEVICES MARKET SNAPSHOT
  • FIGURE 25: ROW: ANTI-SNORING DEVICES MARKET SNAPSHOT
  • FIGURE 26: KEY PLAYERS ADOPTED INORGANIC AS WELL AS ORGANIC GROWTH STRATEGIES BETWEEN 2012 & 2015
  • FIGURE 27: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY ADOPTED BY PLAYERS BETWEEN 2012 AND 2015
  • FIGURE 28: SOMNOMED LIMITED: COMPANY SNAPSHOT
  • FIGURE 29: GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
Back to Top